ArticleMolecular oncology2016

EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer.

Arjan Gower et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.